BPC-157
250–500 mcg · Daily or ED
Evidence
- Human Studies
- 3
- Animal Studies
- 60
- Clinical Status
- Research
- Confidence
- Low
- Long-Term Safety
- Unknown — no long-term human safety data published
What this score is: a measure of how much research exists and how far along it is (animal-only vs. human trials, research-stage vs. FDA approved) — not how safe, effective, or worth trying a compound is. A low score usually means “early stage” or “understudied,” not “bad.” A high score doesn’t mean “better” for your goals than a lower-scored one.
This is not my personal rating of the compound, not a recommendation, and not medical advice. It’s a general research synthesis for informational purposes only, not a live literature count. See the linked research and talk to a licensed clinician before making decisions based on it.
Mechanism
A synthetic fragment derived from a protein found in gastric juice, studied in rodent models for effects on angiogenesis and tissue repair signaling — particularly gut lining, tendon, and ligament healing.
Common Protocols
- 250–500 mcg once or twice daily, subcutaneous or near the site of injury
- Typical research cycles run 4–8 weeks
Side Effects
- Injection site irritation
- Limited formal adverse-event data in humans
Interactions
- Little formal drug-interaction research exists
Practical Details
- Cost
- $
- Typical Vial Size
- 5 mg
- Storage
- Refrigerate after reconstitution; use within 2–4 weeks for best stability
Research Links
Gut healing, injury repair, anti-inflammatory